The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.
about
A cell permeable peptide inhibitor of NFAT inhibits macrophage cytokine expression and ameliorates experimental colitisA prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients.Paediatric transplantation comes of age. The main problem now is shortage of donors
P2860
The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
The superiority of tacrolimus ...... -- the Pittsburgh experience.
@ast
The superiority of tacrolimus ...... -- the Pittsburgh experience.
@en
The superiority of tacrolimus ...... -- the Pittsburgh experience.
@nl
type
label
The superiority of tacrolimus ...... -- the Pittsburgh experience.
@ast
The superiority of tacrolimus ...... -- the Pittsburgh experience.
@en
The superiority of tacrolimus ...... -- the Pittsburgh experience.
@nl
prefLabel
The superiority of tacrolimus ...... -- the Pittsburgh experience.
@ast
The superiority of tacrolimus ...... -- the Pittsburgh experience.
@en
The superiority of tacrolimus ...... -- the Pittsburgh experience.
@nl
P2093
P2860
P1433
P1476
The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience
@en
P2093
H A Gritsch
J McCauley
M L Jordan
V P Scantlebury
P2860
P304
P577
1995-01-01T00:00:00Z